Access the Akari CEO Corner here TAMPA, Fla. and LONDON, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payloads for antib ...
Among the most famous demonstrations of genetic mutations driving infection outcome is severe combined immunodeficiency (SCID ...
Hijacking the energy-producing organelles from immune cells seems to help tumours in mice to infiltrate lymph nodes.
These underground rodents are the first mammals found to actively choose air with lower-than-normal oxygen levels. Their ...